Changes in the Lémann Index Values During the First Years of Crohn's Disease

Clinical Gastroenterology and Hepatology

Volumn 13, Issue 9, 2015, Pages 1633-1640.e3

  Gilletta, Cyrielle ^a   Lewin, Maïté ^b   Bourrier, Anne ^c,e   Nion Larmurier, Isabelle ^c,e   Rajca, Sylvie ^c,e   Beaugerie, Laurent ^c,e   Sokol, Harry ^c,e   Pariente, Benjamin ^d   Seksik, Philippe ^c,e   Cosnes, Jacques ^c,e  

^a Centre Hospitalo Universitaire de Caen   (France)

^b HÔPITAL PAUL BROUSSE   (France)

^c HÔPITAL SAINT ANTOINE   (France)

^d LILLE UNIVERSITY HOSPITAL   (France)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Computed Tomography; Inflammatory Bowel Disease; Magnetic Resonance Imaging; Surgery

Indexed keywords

IMMUNOMODULATING AGENT; TUMOR NECROSIS FACTOR ANTIBODY;

ADULT; ARTICLE; CALCULATION; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; CROHN DISEASE; DIGESTIVE SYSTEM INJURY; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; INTESTINE RESECTION; LEMANN INDEX SCORE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRESCRIPTION; SCORING SYSTEM; DISEASE COURSE; INTESTINE MUCOSA; LONGITUDINAL STUDY; PATHOLOGY; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; TIME FACTOR; YOUNG ADULT;

ADULT; CROHN DISEASE; DISEASE PROGRESSION; FEMALE; HUMANS; INTESTINAL MUCOSA; LONGITUDINAL STUDIES; MALE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; YOUNG ADULT;

EID: 84939565750     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2015.02.041     Document Type: Article

References (18)

1. Cosnes J., Cattan S., Blain A., et al. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis 2002, 8:244-250.
2. Louis E., Collard A., Oger A.F., et al. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut 2001, 49:777-782.
3. Thia K.T., Sandborn W.J., Harmsen W.S., et al. Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort. Gastroenterology 2010, 139:1147-1155.
4. Eglinton T.W., Barclay M.L., Gearry R.B., et al. The spectrum of perianal Crohn's disease in a population-based cohort. Dis Colon Rectum 2012, 55:773-777.
5. Munkholm P., Langholz E., Davidsen M., et al. Disease activity courses in a regional cohort of Crohn's disease patients. Scand J Gastroenterol 1995, 30:699-706.
6. Cosnes J., Nion-Larmurier I., Beaugerie L., et al. Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery. Gut 2005, 54:237-241.
7. Ramadas A.V., Gunesh S., Thomas G.A., et al. Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates. Gut 2010, 59:1200-1206.
8. Colombel J.F., Schwartz D.A., Sandborn W.J., et al. Adalimumab for the treatment of fistulas in patients with Crohn's disease. Gut 2009, 58:940-948.
9. Lichtenstein G.R., Yan S., Bala M., et al. Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease. Gastroenterology 2005, 128:862-869.
10. Frolkis A.D., Dykeman J., Negron M.E., et al. Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies. Gastroenterology 2013, 145:996-1006.
11. Cosnes J., de Parades V., Carbonnel F., et al. Classification of the sequelae of bowel resection for Crohn's disease. Br J Surg 1994, 81:1627-1631.
12. Allen P.B., Kamm M.A., Peyrin-Biroulet L., et al. Development and validation of a patient-reported disability measurement tool for patients with inflammatory bowel disease. Aliment Pharmacol Ther 2013, 37:438-444.
13. Pariente B., Mary J.Y., Danese S., et al. Development of the Lemann Index to assess digestive tract damage in patients with Crohn's disease. Gastroenterology 2015, 148:52-63.
14. Lennard-Jones J.E. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989, 170:2-6. discussion 16-19.
15. Cosnes J., Bourrier A., Nion-Larmurier I., et al. Factors affecting outcomes in Crohn's disease over 15 years. Gut 2012, 61:1140-1145.
16. Panes J., Bouzas R., Chaparro M., et al. Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn's disease. Aliment Pharmacol Ther 2011, 34:125-145.
17. Fiorino G., Bonifacio C., Peyrin-Biroulet L., et al. Prospective comparison of computed tomography enterography and magnetic resonance enterography for assessment of disease activity and complications in ileocolonic Crohn's disease. Inflamm Bowel Dis 2011, 17:1073-1080.
18. Jensen M.D., Ormstrup T., Vagn-Hansen C., et al. Interobserver and intermodality agreement for detection of small bowel Crohn's disease with MR enterography and CT enterography. Inflamm Bowel Dis 2011, 17:1081-1088.